IVVD ▲ +3.2% - Invivyd, Inc.
$IVVD - Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311
29-SEP-2026 07:01 AM ET
Share this post
More filings for $IVVD
IVVD ▲ +1.5% - Invivyd, Inc.Oct 14, 2026IVVD ▲ +4.8% - Invivyd, Inc.Sep 8, 2026IVVD ▲ +6.2% - Invivyd, Inc.Sep 3, 2026IVVD ▼ -2.1% - Invivyd, Inc.Sep 1, 2026IVVD - Invivyd, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 15, 2026$IVVD SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 28, 2026
View full $IVVD filing history →💬 Comments
Loading comments…
Leave a comment